| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |